Antidepressant Properties of Proproten and Amitriptyline: Comparative Experimental Study

被引:3
|
作者
O. I. Epstein
G. M. Molodavkin
T. A. Voronina
S. A. Sergeeva
机构
[1] “Materia Medica Holding” Research-and-Production Company,
关键词
antibodies against S100 protein; ultralow doses; Proproten; antidepressant activity; amitriptyline; behavioral helplessness; swimming in reservoir with wheels;
D O I
10.1023/A:1024724023144
中图分类号
学科分类号
摘要
Antidepressant properties of Proproten (antibodies to S100 protein in ultralow doses) were studied on outbred albino rats. The animals were subjected to the Porsolt's test of behavioral helplessness and Nomura's test of forced swimming in a reservoir with freely rotating wheels. Proproten in a dose of 2.5 ml/kg produced a strong antidepressant effect. It was observed after single and repeated (5 days) peroral treatment with the preparation. Proproten decreased the immobility time (Porsolt's test) and increased the number of wheel turns (Nomura's test). The activity of Proproten compared well with the standard preparation amitriptyline. As differentiated from amitriptyline, Proproten did not produce the sedative effect.
引用
收藏
页码:123 / 124
页数:1
相关论文
共 50 条
  • [21] EXPERIMENTAL STUDY OF DIRECT VASCULAR ACTIVITY OF AMITRIPTYLINE
    LAMARCHE, M
    ROYER, R
    HEISEL, J
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1967, 161 (11): : 2241 - &
  • [22] Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: a randomized comparative study
    Dias, Michelle
    Santiago, Santos
    Carvalho, Deusvenir de Souza
    Gabbai, Alberto Alain
    Machado, Mariana
    Pinto, Pereira
    Correa Moutran, Andrea Regina
    Villa, Thais Rodrigues
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2014, 72 (11) : 851 - 855
  • [23] Genotoxic evaluation for the tricyclic antidepressant drug, amitriptyline
    Hassanane, Mohamed S.
    Hafiz, Naglaa
    Radwan, Walaa
    El-Ghor, Akmal A.
    DRUG AND CHEMICAL TOXICOLOGY, 2012, 35 (04) : 450 - 455
  • [24] Amitriptyline: Dual-action antidepressant? Reply
    Thase, ME
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1391 - 1392
  • [25] Preclinical Study of Proproten-100 for Mutagenicity
    O. L. Voronova
    Bulletin of Experimental Biology and Medicine, 2009, 148 : 547 - 548
  • [26] AMITRIPTYLINE + PERPHENAZINE - EFFECTIVE TRANQUILIZER - ANTIDEPRESSANT COMBINATION
    SHUBIN, H
    MANDEL, S
    PSYCHOSOMATICS, 1967, 8 (02) : 79 - 81
  • [27] Neuroprotective activity of proproten in experimental model of cerebral hemorrhagic stroke
    Sergeeva, SA
    Dugina, JL
    Martyushev-Poklad, AV
    Epstein, OI
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S241 - S242
  • [28] COMPARATIVE-STUDY OF LEVOPROTILINE AND AMITRIPTYLINE IN ENDOGENOUS DEPRESSIONS
    FALTUS, F
    MOLCAN, J
    SVESTKA, J
    NAHUNEK, K
    MRNA, B
    ZAPLETALEK, M
    KREKULE, P
    JANECKOVA, E
    KONIKOVA, M
    PAZDIREK, S
    WENDT, G
    ACTIVITAS NERVOSA SUPERIOR, 1989, 31 (04): : 279 - 280
  • [29] A COMPARATIVE-STUDY OF BUPROPION AND AMITRIPTYLINE IN DEPRESSED OUTPATIENTS
    MENDELS, J
    AMIN, MM
    CHOUINARD, G
    COOPER, AJ
    MILES, JE
    REMICK, RA
    SAXENA, B
    SECUNDA, SK
    SINGH, AN
    JOURNAL OF CLINICAL PSYCHIATRY, 1983, 44 (05) : 118 - 120
  • [30] A COMPARATIVE-STUDY OF AMITRIPTYLINE AND FLUVOXAMINE IN MIGRAINE PROPHYLAXIS
    BANK, J
    HEADACHE, 1994, 34 (08): : 476 - 478